Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets

The objective of the present study was to evaluate the potential risks of the four commercial PRRS-1 MLV vaccines in pregnant vaccinated gilts at the last stage of gestation under field conditions. The study was conducted at four pig farms, including 25 gilts from each farm (25 × 4 = 100 gilts), whi...

Full description

Bibliographic Details
Main Authors: Georgios Papakonstantinou, Eleftherios Meletis, Georgios Christodoulopoulos, Eleni D. Tzika, Polychronis Kostoulas, Vasileios G. Papatsiros
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/12/4/450
_version_ 1827657706381508608
author Georgios Papakonstantinou
Eleftherios Meletis
Georgios Christodoulopoulos
Eleni D. Tzika
Polychronis Kostoulas
Vasileios G. Papatsiros
author_facet Georgios Papakonstantinou
Eleftherios Meletis
Georgios Christodoulopoulos
Eleni D. Tzika
Polychronis Kostoulas
Vasileios G. Papatsiros
author_sort Georgios Papakonstantinou
collection DOAJ
description The objective of the present study was to evaluate the potential risks of the four commercial PRRS-1 MLV vaccines in pregnant vaccinated gilts at the last stage of gestation under field conditions. The study was conducted at four pig farms, including 25 gilts from each farm (25 × 4 = 100 gilts), which were equally allocated to five different study groups. A PRRS-1 MLV vaccination was applied on the 100th day of their pregnancy with the different commercial vaccines that are available in the Greek market. The results indicated virus congenital infection and viremia in piglets (20/200 = 10% PRRSV infected piglets), and detection of PRRSV-specific antibodies (181/200 = 90.5% piglets found with PRRSV antibodies). The subsequent phylogenetic analyses revealed high percentages of similarity between the PRRSV-1 strain detected in infected litters and the PRRSV-1 vaccine strain to which the study gilts had been previously exposed to. Health status analyses of trial piglets resulted in differences between litters from vaccinated sows and litters from non-vaccinated sows at 110th day of gestation as regards the number of weak-born piglets, mummies, and piglets with splay-leg and/or respiratory symptoms. The current study’s results indicate several potential dangers of the PRRS MLV vaccination in late gestation.
first_indexed 2024-03-09T22:48:47Z
format Article
id doaj.art-d37baa1da0e9438990a06805d2a476e5
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-09T22:48:47Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-d37baa1da0e9438990a06805d2a476e52023-11-23T18:25:19ZengMDPI AGAnimals2076-26152022-02-0112445010.3390/ani12040450Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of PigletsGeorgios Papakonstantinou0Eleftherios Meletis1Georgios Christodoulopoulos2Eleni D. Tzika3Polychronis Kostoulas4Vasileios G. Papatsiros5Clinic of Medicine, Faculty of Veterinary Medicine, School of Health Sciences, University of Thessaly, 43100 Karditsa, GreeceLaboratory of Epidemiology & Artificial Intelligence, Faculty of Public Health, School of Health Sciences, University of Thessaly, 43100 Karditsa, GreeceClinic of Medicine, Faculty of Veterinary Medicine, School of Health Sciences, University of Thessaly, 43100 Karditsa, GreeceFarm Animals Clinic, School of Veterinary Medicine, Aristotle University of Thessaloniki, 54627 Thessaloniki, GreeceLaboratory of Epidemiology & Artificial Intelligence, Faculty of Public Health, School of Health Sciences, University of Thessaly, 43100 Karditsa, GreeceClinic of Medicine, Faculty of Veterinary Medicine, School of Health Sciences, University of Thessaly, 43100 Karditsa, GreeceThe objective of the present study was to evaluate the potential risks of the four commercial PRRS-1 MLV vaccines in pregnant vaccinated gilts at the last stage of gestation under field conditions. The study was conducted at four pig farms, including 25 gilts from each farm (25 × 4 = 100 gilts), which were equally allocated to five different study groups. A PRRS-1 MLV vaccination was applied on the 100th day of their pregnancy with the different commercial vaccines that are available in the Greek market. The results indicated virus congenital infection and viremia in piglets (20/200 = 10% PRRSV infected piglets), and detection of PRRSV-specific antibodies (181/200 = 90.5% piglets found with PRRSV antibodies). The subsequent phylogenetic analyses revealed high percentages of similarity between the PRRSV-1 strain detected in infected litters and the PRRSV-1 vaccine strain to which the study gilts had been previously exposed to. Health status analyses of trial piglets resulted in differences between litters from vaccinated sows and litters from non-vaccinated sows at 110th day of gestation as regards the number of weak-born piglets, mummies, and piglets with splay-leg and/or respiratory symptoms. The current study’s results indicate several potential dangers of the PRRS MLV vaccination in late gestation.https://www.mdpi.com/2076-2615/12/4/450PRRSVantibodiesMLV vaccinesafetypiglet
spellingShingle Georgios Papakonstantinou
Eleftherios Meletis
Georgios Christodoulopoulos
Eleni D. Tzika
Polychronis Kostoulas
Vasileios G. Papatsiros
Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
Animals
PRRSV
antibodies
MLV vaccine
safety
piglet
title Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
title_full Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
title_fullStr Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
title_full_unstemmed Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
title_short Heterologous Challenge with PRRSV-1 MLV in Pregnant Vaccinated Gilts: Potential Risk on Health and Immunity of Piglets
title_sort heterologous challenge with prrsv 1 mlv in pregnant vaccinated gilts potential risk on health and immunity of piglets
topic PRRSV
antibodies
MLV vaccine
safety
piglet
url https://www.mdpi.com/2076-2615/12/4/450
work_keys_str_mv AT georgiospapakonstantinou heterologouschallengewithprrsv1mlvinpregnantvaccinatedgiltspotentialriskonhealthandimmunityofpiglets
AT eleftheriosmeletis heterologouschallengewithprrsv1mlvinpregnantvaccinatedgiltspotentialriskonhealthandimmunityofpiglets
AT georgioschristodoulopoulos heterologouschallengewithprrsv1mlvinpregnantvaccinatedgiltspotentialriskonhealthandimmunityofpiglets
AT elenidtzika heterologouschallengewithprrsv1mlvinpregnantvaccinatedgiltspotentialriskonhealthandimmunityofpiglets
AT polychroniskostoulas heterologouschallengewithprrsv1mlvinpregnantvaccinatedgiltspotentialriskonhealthandimmunityofpiglets
AT vasileiosgpapatsiros heterologouschallengewithprrsv1mlvinpregnantvaccinatedgiltspotentialriskonhealthandimmunityofpiglets